Programmes

Psychedelic Practitioner Training

PsyEdu and PsyTrain are pleased to announce the launch of Psychedelic Practitioner Training: an intensive 14-week professional programme for healthcare professionals, psychotherapists, counsellors and experienced practitioners preparing to work responsibly with psychedelic-assisted approaches.
14 weeks
11 January to 12 April, 2027
Online
Live training on NZ time
$6,300 (NZD)
Course fee
30 students
Restricted cohort size
From foundational knowledge to practical delivery

Psychedelic-assisted therapies are developing rapidly. Safe and responsible practice requires considerably more than learning a treatment protocol over a few days.

This programme offers an extended learning journey in which participants can acquire knowledge, reflect on its implications, discuss complex questions with peers and experienced practitioners, and begin translating theory into ethically and culturally responsive practice.

The programme progresses from history, pharmacology and the clinical evidence into the practical realities of screening, preparation, therapeutic support, boundaries, challenging experiences, integration, service design and professional practice.

Particular attention is given to the distinctive cultural and healthcare landscape of Aotearoa, including Indigenous perspectives, mushrooms of Aotearoa and the emerging regulatory environment for psychedelic-assisted therapies in New Zealand.

Who is the programme for?

Psychedelic Practitioner Training is intended for a multidisciplinary professional cohort.

Applications will be considered individually to ensure that participants have an appropriate professional background, scope of practice and readiness for the programme.

Completion of the course does not in itself confer authority to prescribe or administer psychedelic medicines. It provides relevant professional education for those wishing to understand and prepare for work within New Zealand’s emerging legal and clinical landscape.

1.
Doctors, nurses and other healthcare professionals
2.
Psychologists, psychotherapists and counsellors
3.
Allied health and complementary healthcare practitioners
4.
Experienced psychedelic practitioners seeking to deepen and formalise their knowledge
5.
Professionals preparing to contribute to psychedelic-assisted services, research or education
A rich and sustained learning experience
The programme incorporates approximately 150 hours of professional learning across three interconnected elements.
Self-directed study

Participants work through ten core topics, each containing:

  • an expert recorded presentation
  • carefully selected reading and viewing
  • structured reflective practice
  • self-assessment activities

 

Additional learning is organised around five themes that recur throughout the programme, connecting the individual topics with broader questions of ethics, safety, cultural responsiveness, self-awareness and professional development.

Live online teaching

Live teaching provides regular opportunities to explore the material with faculty, tutors and fellow participants. It includes:

  • weekly two-hour facilitated Learning Pods
  • one-hour tutorials approximately every other week
  • three-hour Saturday-morning Intensive Sessions approximately every two weeks
  • dedicated pastoral support and professional-development supervision

 

Learning Pods provide a consistent small group in which participants can discuss each topic, work through cases and ethical dilemmas, develop practical skills and relate the teaching to their own professional context.

The fortnightly Intensives bring the wider cohort together for expert teaching, discussion, experiential and reflective learning, and engagement with both international and New Zealand-based contributors.

Wider and interdisciplinary perspectives

The core curriculum is complemented by:

  • trauma and psychedelic-assisted therapy
  • philosophy of mind and non-materialist perspectives
  • microdosing and psychedelic use outside clinical settings
  • psychedelics in recreational, contemplative and natural settings
  • music within psychedelic-assisted therapy

The curriculum

1. History and Culture—including mushrooms of Aotearoa
Historical, cultural and Indigenous perspectives on psychedelic use, from traditional practices to the modern psychedelic renaissance, including the ecology and cultural context of psychoactive fungi in Aotearoa New Zealand.
The pharmacology of psilocybin, MDMA and ketamine; the neuroscience of altered states; and contemporary psychological and neurobiological models of psychedelic action.
The current evidence for psychedelic-assisted approaches across mental-health and other clinical indications, including the strengths and limitations of existing research and important emerging areas.
Participant assessment, contraindications, risk factors, informed consent, expectation-setting and preparation for safer and potentially beneficial psychedelic experiences.
The phenomenology of psychedelic states, including common experiences, therapeutic processes, mystical and transpersonal phenomena, and the personal, relational and contextual factors that can influence outcomes.
Ethical practice, professional boundaries, consent, the use of touch, power dynamics and safeguarding within psychedelic care.
The recognition, prevention and management of difficult psychedelic experiences, psychological crises and adverse events, including emergency considerations and post-session support.
Supporting people to make meaning from psychedelic experiences and translate insights into sustainable psychological, behavioural, relational and practical change.
Contemporary models of psychedelic-assisted therapy, therapeutic approaches, practitioner and facilitator roles, and the practical realities of delivering psychedelic care.
The legal, regulatory, operational, ethical and governance considerations involved in establishing and delivering psychedelic-assisted services within New Zealand’s evolving healthcare landscape.
International expertise, grounded in Aotearoa

The programme brings together internationally recognised researchers, clinicians, educators and practitioners alongside contributors with knowledge of New Zealand’s culture, communities, healthcare system and emerging psychedelic landscape.

Confirmed contributors include:

Prof David Nutt Headshot
Professor David Nutt
An internationally recognised neuropsychopharmacologist and leading researcher in psychedelic science, drug policy and the clinical development of psychedelic-assisted therapies.
Professor David Luke
A professor at the University of Greenwich, whose research explores altered states of consciousness, psychedelics, and anomalous human experience through the lens of psychology and parapsychology.
Suresh Muthukumaraswamy Headshot
Associate Professor Suresh Muthukumaraswamy
A leading psychedelic researcher at the University of Auckland whose work uses psychopharmacology, neuroimaging and advanced research methods to investigate how psychedelics and other emerging therapies affect brain function.
Dr Lauren Macdonald
A psychiatrist, researcher and educator whose work combines clinical knowledge with personal experience and a strong interest in the responsible development of psychedelic-assisted care.
Dr James Andrew Simonsson headshot
Dr James Simonsson
A consultation-liaison psychiatrist at Tauranga Hospital focused on indigenous cultural frameworks in psychiatric care and Māori mental health. Interested in psychedelic-assisted psychotherapy’s role in harm reduction and culturally informed care.
Bianca Sebben headshot
Dr Bianca Sebben
Co-Founder of IPAT and a Clinical Psychologist in Brisbane focused on complex trauma and working with Aboriginal and Torres Strait Islander peoples. Her interest in plant medicine began during her PhD in Indigenous Psychology in Mexico.
Shaun Te Rire McNeil headshot
Shaun Te Rire McNeil
A Lecturer in Science and Mātauranga Māori at the University of Waikato, whose work bridges chemistry, neuroscience and Māori knowledge systems, including research on natural compounds and appetite pharmacology.
Sam Lasham Headshot
Sam Lasham
A PhD candidate in the School of Pharmacy studying how chemical variation in psilocybin mushroom species affects user experiences, using a Drug Checking licence. Founder and national coordinator of Students for Sensible Drug Policy Aotearoa.
Musheerah Nuha headshot
Musheerah Nuha
A Health Psychologist and Research Evaluator in Tāmaki Makaurau focused on cultural safety and equity in healthcare, including research on Pacific perspectives on psychedelic-assisted therapies.
Stuart McDonald headshot
Stuart McDonald
Founder of the Ahipoutu Collective, working as Tumu Whakarae (chief executive/leader) and Tohunga tā moko (master tattoo practitioner), blending traditional and contemporary toi Māori to support healing, cultural identity, and self-determination.
Jem Stone Headshot
Jem Stone
Co-Founder and Director of IPAT, a Bundjalung First Nations woman working at the intersection of Indigenous wisdom, trauma recovery, and psychedelic-assisted care. Co-designed the IPAT model of care and contributed to Australia’s MDMA guidelines.
Sahra Kress headshot
Sahra Kress
A community midwife with 20+ years’ experience, working at the intersection of rites of passage, collapse psychology, and plant medicines. Offers ceremonial cactus experiences and community integration as well.
James Bunn Headshot
James Bunn
Co-founder of PsyTrain NZ, with a background in life sciences, biotech, and law, having worked with the Beckley Foundation, Drug Science, PAREA, and TheraPsil. Focused on using Real World Evidence to inform psychedelic medicine regulation.
Adam Waugh Headshot
Adam Waugh
Co-founder of PsyTrain NZ, with a background in psychedelic harm reduction and drug policy reform. Senior manager at PsyCare UK (2019–2024) and Training Coordinator at The Loop. Co-founder and co-director of PsyAware.
$6,300 (NZD)

+ $250 (NZD) non-refundable enrolment fee

Save $300 (NZD) on the standard course fee if you are among the first 10 applicants to complete enrolment before October 23rd. To qualify, you must be accepted onto the programme and pay the $250 (NZD) enrolment fee and $2,000 (NZD) deposit before the deadline.

The Early Bird rate is based on the date you complete enrolment, not the date you submit your application. The application, interview, references and payment process can take up to 10 days, so we strongly recommend applying well before the deadline.

Bursaries and accessibility

We recognise that the cost of professional education can be a significant barrier. A limited number of bursaries will be available for:

  • practitioners on lower incomes
  • Māori, Pacific peoples and members of other marginalised or under-represented communities
  • LGBTQ+ practitioners and others whose perspectives are under-represented within healthcare and psychedelic practice
  • practitioners who can demonstrate an established commitment to serving marginalised, deprived or underserved communities

 

Applicants will be invited to provide relevant information as part of a confidential bursary application. Availability is limited, and support will be allocated according to financial need, representation and likely community benefit.

Join the first cohort
11 January – 12 April 2027 | Online Training | $6,300 (NZD)

The PsyEdu Psychedelic Practitioner Training offers an opportunity to develop rigorous foundational knowledge while joining a sustained professional learning community.

Over 14 weeks, participants will encounter leading international and local perspectives, examine the difficult ethical and practical questions facing the field, and begin developing the knowledge, judgement and reflective capacity required for responsible psychedelic practice.

Places are limited to 30 participants. Applications open on September 23rd and close December 1st.

Apply early to secure your spot.